Key result
Amlodipine increases sympathetic nerve activity more than nifedipine GITS despite similar blood pressure reductions.
Why the study?
Does amlodipine differ from nifedipine GITS in its effect on sympathetic nervous system activation and blood pressure reduction in patients with hypertension?
Systematic Review (n=989)
Does amlodipine differ from nifedipine GITS in its effect on sympathetic nervous system activation and blood pressure reduction in patients with hypertension?
Both amlodipine and nifedipine GITS effectively lower blood pressure with minimal heart rate changes (<1 beat/min), though amlodipine causes a numerically greater increase in sympathetic nervous system activity markers than nifedipine GITS, demonstrating that long-acting dihydropyridine CCBs are not a completely homogeneous drug class.
Answers are grounded in this paper and cite their sources.
Amlodipine may increase sympathetic activity more than nifedipine GITS despite similar BP reduction; challenges homogeneity among long-acting dihydropyridine CCBs.
Calcium-channel blockers (CCBs) constitute a diverse group of compounds but are often referred to as a single homogeneous class of drug and the clinical responses indiscriminately summarized. Even within the dihydropyridine subgroup, there are significant differences in formulations, pharmacokinetics, durations of action and their effects on blood pressure, heart rate, end organs and the sympathetic nervous system. Amlodipine and nifedipine in the gastrointestinal therapeutic system (GITS) formulation are the most studied of the once-daily CCBs. Amlodipine has an inherently long pharmacokinetic half-life, whereas, in contrast, nifedipine has an inherently short half-life but in the GITS formulation the sophisticated delivery system allows for once-daily dosing. This article is derived from a systematic review of the published literature in hypertensive patients. The following search terms in three main databases (MEDLINE, Embase, Science Citation Index) from 1990 to 2011 were utilized: amlodipine, nifedipine, sympathetic nervous system, sympathetic response, sympathetic nerve activity, noradrenaline, norepinephrine and heart rate. More than 1500 articles were then screened to derive the relevant analysis. As markers of sympathetic nervous system activation, studies of plasma norepinephrine concentrations, power spectral analysis, muscle sympathetic nerve activity and norepinephrine spillover were reviewed. Overall, each drug lowered blood pressure in hypertensive patients in association with only small changes in heart rate (i.e. <1 beat/min). Plasma norepinephrine concentrations, as the most widely reported marker of sympathetic nervous system activity, showed greater increases in patients treated with amlodipine than with nifedipine GITS. The evidence indicates that both these once-daily dihydropyridine CCBs lower blood pressure effectively with minimal effects on heart rate. There are small differences between the drugs in the extent to which each activates the sympathetic nervous system with an overall non-significant trend in favour of nifedipine GITS.
No takes yet. Share an insight, caveat, or question.
Toal et al. (2012) conducted a systematic review in Hypertension (n=989). Amlodipine vs. Nifedipine gastrointestinal therapeutic system (GITS) 20 to 150 mg once daily was evaluated on Percentage change from baseline in plasma norepinephrine (NE) concentration. Amlodipine increased plasma norepinephrine by 21.7% and muscle sympathetic nerve activity by and 6.7% with nifedipine GITS, while both lowered blood pressure similarly.
Synapse has enriched 10 related papers. Consider them for comparative context: